XPH vs. BBH: Healthcare ETF Comparison Highlights Key Metrics

The State Street SPDR S&P Pharmaceuticals ETF (XPH) features a broader portfolio with 65 holdings compared to the 25 biotechnology leaders of the VanEck Biotech ETF (BBH). Both funds have identical annual expense ratios of 0.35% and yield 0.50%. Over the past year, total returns have significantly diverged, with XPH offering less volatility. This information is crucial for investors seeking stable, diversified exposure in the healthcare sector, especially given the consistent demand for medical products regardless of economic conditions.